Form 4/A for BSX Boston Scientific
Accepted 2023-02-21 00:00:00 ET · period of report 2023-02-15 · accession 0001225208-23-002350 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2023-02-21 | 2023-02-15 | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | F - Tax | $47.29 | -2,278 | 212.2K | -1% | -$107.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-15 | F | D | 2,278 | $47.29 | 212,164 | D | — | — |